CapsoVision announces FDA clearance for AI Highlights
The tool assists physicians in reviewing small bowel capsule endoscopy images by highlighting suspected abnormal lesions to improve efficiency and reading performance.
See the latest news and media coverage for CapsoVision. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical device company specializing in gastrointestinal diagnostic imaging
capsovision.comLast updated
In short: CapsoVision secured FDA clearance for AI Highlights and mapped expansion into additional cancer-screening applications.
The tool assists physicians in reviewing small bowel capsule endoscopy images by highlighting suspected abnormal lesions to improve efficiency and reading performance.
Revenue grew 10% to $3.6M, AI Highlights launched in EU, FDA clearance expected Q3.
The company will host a conference call and webcast at 1:30 pm PT on August 13 to discuss the results and provide a corporate update.
Revenue stable at $2.8 million; operating loss rose to $7.0 million on higher R&D and tariff costs.
"The second quarter marked another important step in the evolution of CapsoVision as we advanced both our commercial execution and product innovation. We were pleased...
SARATOGA, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions...
SARATOGA, Calif., March 20, 2026 (GLOBE NEWSWIRE)-- CapsoVision, Inc. (the "Company") (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy...
SARATOGA, Calif., March 26, 2026 -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enab | Bitget crypto news!
Track CapsoVision and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.